Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-10

Clinical Trial Update: Staccato Alprazolam and Photoparoxysmal Response [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Staccato Alprazolam in epilepsy examining photoparoxysmal response; the study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Staccato Alprazolam (Alprazolam)

Snippet

Sponsor: Nova Pneuma Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2021-08-10